Wuhan Huazhong Numerical Control (SHE:300161) received 6.6 million yuan in national science and technology project funding, with the amount to be recognized as other income.
Of the total, 846,000 yuan is asset-related and 5.8 million yuan is income-related, according to a Tuesday filing with the Shenzhen bourse.
Shares of the equipment manufacturer closed 1% lower Wednesday.
Shanghai Fosun Pharmaceutical (SHA:600196, HKG:2196) unit Hebei Wanbang Folon Pharmaceutical's drug registration application for Tao Hong Si Wu Tang Granules was accepted by China's National Medical Products Administration.The drug is intended to be used for blood deficiency and blood stasis syndrome, according to a Wednesday Hong Kong bourse filing.
Resonac's (TYO:4004) profit attributable to owners of the parent rose 75% to 15.3 billion yen for the first quarter from 8.75 billion yen a year earlier.The chemicals company's earnings per share increased to 76.17 yen from 48.44 yen a year ago, according to a Tokyo bourse filing on Wednesday.Revenue slipped 4.1% to 307.9 billion yen for the three months ended March 31 from 321.1 billion yen in the prior-year period.For the year ending Dec. 31, the company expects attributable profit of 77 billion yen, EPS of 425.45 yen, and revenue of 1.31 trillion yen.Resonac plans to pay a year-end dividend of 65 yen per share for the year.
ITC Properties Group (HKG:0199) completed the placing of a little over 69.1 million new shares to raise net proceeds of HK$52.9 million, according to a Wednesday Hong Kong bourse filing.The shares, which were placed to at least six investors at HK$0.8 apiece, represent 6.35% of the property developer's enlarged issued share capital.The firm will use proceeds for investment-related initiatives focusing on AI and technology projects, as well as for the expansion of strategic partnerships to support ongoing projects and overseas growth.